Showing results (321-330 of 499) with videos related to
Sort By:
Pageof 50
Journal of Virology|November 1, 2016
Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion InhibitorsShan Su, Yun Zhu, Sheng Ye, et al.Human Vaccines & Immunotherapeutics|March 10, 2017
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infectionYufei Wang, Wanbo Tai, Jie Yang, et al.BMC Microbiology|March 16, 2017
Genome-wide analysis of an avirulent strain that induces protective immunity against challenge with virulent Streptococcus suis serotype 2Jing Wang, Youjun Feng, Changjun Wang, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 3, 2018
A CCR5 antagonist-based HIV entry inhibitor exhibited potent spermicidal activity: Potential application for contraception and prevention of HIV sexual transmissionMingjun Yang, Ruina Zhi, Lu Lu, et al.Journal of Medicinal Chemistry|December 31, 2010
Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41Shibo Jiang, Srinivasa R Tala, Hong Lu, et al.Fitoterapia|December 14, 2011
A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infectionJie Yang, Lin Li, Suiyi Tan, et al.Nature Communications|September 16, 2015
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibodyTianlei Ying, Ponraj Prabakaran, Lanying Du, et al.Journal of Medicinal Chemistry|September 15, 2009
Design, synthesis, and structure-activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 entry inhibitorsAlan R Katritzky, Srinivasa R Tala, Hong Lu, et al.The Journal of Antimicrobial Chemotherapy|June 25, 2013
An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicidesPei Tong, Zhifeng Lu, Xi Chen, et al.Biochimica Et Biophysica Acta|January 7, 2014
ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimerFei Yu, Lu Lu, Qi Liu, et al.Pageof 50